| UniProt ID | DNJB4_HUMAN | |
|---|---|---|
| UniProt AC | Q9UDY4 | |
| Protein Name | DnaJ homolog subfamily B member 4 | |
| Gene Name | DNAJB4 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 337 | |
| Subcellular Localization | Cytoplasm . Cell membrane . Cytoplasmic according to PubMed:18837411 and membrane-associated according to PubMed:16542645. | |
| Protein Description | Probable chaperone. Stimulates ATP hydrolysis and the folding of unfolded proteins mediated by HSPA1A/B (in vitro). [PubMed: 24318877] | |
| Protein Sequence | MGKDYYCILGIEKGASDEDIKKAYRKQALKFHPDKNKSPQAEEKFKEVAEAYEVLSDPKKREIYDQFGEEGLKGGAGGTDGQGGTFRYTFHGDPHATFAAFFGGSNPFEIFFGRRMGGGRDSEEMEIDGDPFSAFGFSMNGYPRDRNSVGPSRLKQDPPVIHELRVSLEEIYSGCTKRMKISRKRLNADGRSYRSEDKILTIEIKKGWKEGTKITFPREGDETPNSIPADIVFIIKDKDHPKFKRDGSNIIYTAKISLREALCGCSINVPTLDGRNIPMSVNDIVKPGMRRRIIGYGLPFPKNPDQRGDLLIEFEVSFPDTISSSSKEVLRKHLPAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 3 | Malonylation | -----MGKDYYCILG -----CCCCEEEEEE | 41.06 | 26320211 | |
| 13 | Ubiquitination | YCILGIEKGASDEDI EEEEECCCCCCHHHH | 58.83 | - | |
| 24 | Phosphorylation | DEDIKKAYRKQALKF HHHHHHHHHHHHHHH | 27.50 | - | |
| 30 | Ubiquitination | AYRKQALKFHPDKNK HHHHHHHHHCCCCCC | 44.64 | - | |
| 37 | Ubiquitination | KFHPDKNKSPQAEEK HHCCCCCCCHHHHHH | 70.07 | - | |
| 38 | Phosphorylation | FHPDKNKSPQAEEKF HCCCCCCCHHHHHHH | 31.47 | 20068231 | |
| 46 | Ubiquitination | PQAEEKFKEVAEAYE HHHHHHHHHHHHHHH | 63.45 | - | |
| 59 | Ubiquitination | YEVLSDPKKREIYDQ HHHHCCHHHHHHHHH | 70.25 | - | |
| 60 | Ubiquitination | EVLSDPKKREIYDQF HHHCCHHHHHHHHHH | 61.73 | - | |
| 73 | Ubiquitination | QFGEEGLKGGAGGTD HHCCCCCCCCCCCCC | 67.18 | 2190698 | |
| 79 | Phosphorylation | LKGGAGGTDGQGGTF CCCCCCCCCCCCCEE | 35.72 | - | |
| 85 | Phosphorylation | GTDGQGGTFRYTFHG CCCCCCCEEEEEECC | 16.27 | - | |
| 122 | Phosphorylation | RMGGGRDSEEMEIDG CCCCCCCCCCEEECC | 33.81 | 18669648 | |
| 133 | Phosphorylation | EIDGDPFSAFGFSMN EECCCCCCCCCEECC | 28.24 | 23403867 | |
| 138 | Phosphorylation | PFSAFGFSMNGYPRD CCCCCCEECCCCCCC | 16.24 | 20068231 | |
| 142 | Phosphorylation | FGFSMNGYPRDRNSV CCEECCCCCCCCCCC | 7.06 | 20068231 | |
| 148 | Phosphorylation | GYPRDRNSVGPSRLK CCCCCCCCCCHHHHC | 29.37 | 30576142 | |
| 152 | Phosphorylation | DRNSVGPSRLKQDPP CCCCCCHHHHCCCCC | 44.29 | 22210691 | |
| 167 | Phosphorylation | VIHELRVSLEEIYSG CCEEEECCHHHHHCC | 24.51 | 21945579 | |
| 172 | Phosphorylation | RVSLEEIYSGCTKRM ECCHHHHHCCCCHHH | 11.42 | 21945579 | |
| 173 | Phosphorylation | VSLEEIYSGCTKRMK CCHHHHHCCCCHHHH | 32.81 | 21945579 | |
| 175 | S-nitrosylation | LEEIYSGCTKRMKIS HHHHHCCCCHHHHHC | 3.13 | 19483679 | |
| 175 | S-nitrosocysteine | LEEIYSGCTKRMKIS HHHHHCCCCHHHHHC | 3.13 | - | |
| 176 | Phosphorylation | EEIYSGCTKRMKISR HHHHCCCCHHHHHCH | 25.80 | 21945579 | |
| 177 | Acetylation | EIYSGCTKRMKISRK HHHCCCCHHHHHCHH | 55.35 | 25953088 | |
| 201 | Phosphorylation | RSEDKILTIEIKKGW CCCCCEEEEEEECCC | 21.75 | 23403867 | |
| 213 | Malonylation | KGWKEGTKITFPREG CCCCCCCEEECCCCC | 51.08 | 26320211 | |
| 213 | Ubiquitination | KGWKEGTKITFPREG CCCCCCCEEECCCCC | 51.08 | - | |
| 223 | Phosphorylation | FPREGDETPNSIPAD CCCCCCCCCCCCCCC | 32.29 | 18669648 | |
| 236 | Ubiquitination | ADIVFIIKDKDHPKF CCEEEEECCCCCCCC | 54.64 | - | |
| 248 | Phosphorylation | PKFKRDGSNIIYTAK CCCCCCCCCEEEEEE | 29.19 | 26657352 | |
| 252 | Phosphorylation | RDGSNIIYTAKISLR CCCCCEEEEEEEEHH | 9.24 | 26657352 | |
| 253 | Phosphorylation | DGSNIIYTAKISLRE CCCCEEEEEEEEHHH | 15.86 | 26657352 | |
| 280 | Phosphorylation | DGRNIPMSVNDIVKP CCCCCCCCHHHHCCC | 16.65 | 20068231 | |
| 286 | Ubiquitination | MSVNDIVKPGMRRRI CCHHHHCCCCCCCCE | 35.87 | - | |
| 296 | Phosphorylation | MRRRIIGYGLPFPKN CCCCEEEECCCCCCC | 12.70 | - | |
| 302 | Ubiquitination | GYGLPFPKNPDQRGD EECCCCCCCHHCCCC | 79.90 | - | |
| 332 | Ubiquitination | SSKEVLRKHLPAS-- CCHHHHHHHCCCC-- | 45.38 | - |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of DNJB4_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of DNJB4_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of DNJB4_HUMAN !! | ||||||
| Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
|---|---|---|---|---|
| HSP76_HUMAN | HSPA6 | physical | 21988832 | |
| SMAD3_HUMAN | SMAD3 | physical | 21988832 | |
| MDM2_HUMAN | MDM2 | physical | 21988832 | |
| TBL1X_HUMAN | TBL1X | physical | 21988832 | |
| DPYL1_HUMAN | CRMP1 | physical | 22863883 | |
| RANB3_HUMAN | RANBP3 | physical | 22863883 | |
| DNJB5_HUMAN | DNAJB5 | physical | 26186194 | |
| DNJB1_HUMAN | DNAJB1 | physical | 26186194 | |
| BGAL_HUMAN | GLB1 | physical | 26186194 | |
| SYNEM_HUMAN | SYNM | physical | 26186194 | |
| CC038_HUMAN | C3orf38 | physical | 26186194 | |
| TTL12_HUMAN | TTLL12 | physical | 26186194 | |
| ERF1_HUMAN | ETF1 | physical | 26344197 | |
| HYOU1_HUMAN | HYOU1 | physical | 26344197 | |
| STIP1_HUMAN | STIP1 | physical | 26344197 | |
| NPM_HUMAN | NPM1 | physical | 20145123 | |
| DNJB1_HUMAN | DNAJB1 | physical | 28514442 | |
| SYNEM_HUMAN | SYNM | physical | 28514442 | |
| DNJB5_HUMAN | DNAJB5 | physical | 28514442 | |
| CC038_HUMAN | C3orf38 | physical | 28514442 | |
| TTL12_HUMAN | TTLL12 | physical | 28514442 | |
| BGAL_HUMAN | GLB1 | physical | 28514442 | |
| NUDC_HUMAN | NUDC | physical | 27173435 |
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Phosphorylation | |
| Reference | PubMed |
| "A quantitative atlas of mitotic phosphorylation."; Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,Elledge S.J., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-122, AND MASSSPECTROMETRY. | |
| "Immunoaffinity profiling of tyrosine phosphorylation in cancercells."; Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,Zha X.-M., Polakiewicz R.D., Comb M.J.; Nat. Biotechnol. 23:94-101(2005). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-172, AND MASSSPECTROMETRY. | |